Lymphoma Awareness

Brian T. Hill, MD, PhD

Hill reports consultant/advisory roles with ADC Therapeutics, AstraZeneca, Bristol Myers Squibb, Genentech, Gilead, Morphosis and Novartis.
May 26, 2023
1 min watch
Save

VIDEO: Health disparities in DLBCL care

Transcript

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Health disparities are a big problem across oncology, and in lymphoma as well. One of the biggest issues we see with disparities is that not all patients get to a referral center that has capabilities of cell therapy or transplant, or clinical trials. And the reasons for that are many. It could be age, it could be socioeconomic factors, it could be geographic factors that preclude patients from always traveling to referral centers. So, that's part of it. And then, of course, there's other more complex reasons related to insurance coverage and other determinants of health outcomes.